Early-Stage NSCLC: Advances in Diagnosis, Tissue Acquisition, and Treatment

Recorded: July 24, 2025

This webinar explores the evolving landscape of diagnosis and treatment for stage I and II non-small cell lung cancer (NSCLC). Viewers will gain critical insights into current best practices in tissue acquisition, including the role of high-quality biopsies and biomarker testing strategies. Expert faculty walk through the latest diagnostic algorithms, highlight key differences in management based on epidermal growth factor receptor and anaplastic lymphoma kinase mutation status, and examine treatment pathways, including surgery, perioperative systemic therapy (including targeted therapy and immunotherapy), and stereotactic body radiation therapy for patients who are inoperable.

The session also addresses interdisciplinary coordination in early-stage lung cancer care and equips clinicians with up-to-date guidance for integrating molecular profiling into therapeutic decision-making.

This non-CME education is brought to you by CHEST and sponsored by AstraZeneca.